These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15552423)

  • 1. On the use of pharmacokinetic models.
    Rescigno A
    Phys Med Biol; 2004 Oct; 49(19):4657-76. PubMed ID: 15552423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On nonoscillation and monotonicity of solutions of nonnegative and compartmental dynamical systems.
    Chellaboina V; Haddad WM; Bailey JM; Ramakrishnan J
    IEEE Trans Biomed Eng; 2004 Mar; 51(3):408-14. PubMed ID: 15000372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check.
    Yano Y; Beal SL; Sheiner LB
    J Pharmacokinet Pharmacodyn; 2001 Apr; 28(2):171-92. PubMed ID: 11381569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compartmental analysis revisited.
    Rescigno A
    Pharmacol Res; 1999 Jun; 39(6):471-8. PubMed ID: 10373243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartmental analysis and its manifold applications to pharmacokinetics.
    Rescigno A
    AAPS J; 2010 Mar; 12(1):61-72. PubMed ID: 19937409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current models in pharmacokinetics: applications in veterinary pharmacology.
    Kinabo LD; McKellar QA
    Vet Res Commun; 1989; 13(2):141-57. PubMed ID: 2672556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodological issues in pharmacokinetic-pharmacodynamic modelling.
    Bellissant E; Sébille V; Paintaud G
    Clin Pharmacokinet; 1998 Aug; 35(2):151-66. PubMed ID: 9739481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closed-loop stability of pharmacokinetic-pharmacodynamic models.
    Wada DR
    Math Biosci; 1997 Dec; 146(2):75-88. PubMed ID: 9348740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local identifiability for two and three-compartment pharmacokinetic models with time-lags.
    Merino JA; De Biasi J; Plusquellec Y; Houin G
    Med Eng Phys; 1998 Jun; 20(4):261-8. PubMed ID: 9728677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development.
    Agoram BM; Demin O
    Drug Discov Today; 2011 Dec; 16(23-24):1031-6. PubMed ID: 22020181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect pharmacodynamic response models do not require any parametric pharmacokinetic model to be fitted to effect-time data.
    Piotrovsky VK
    Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):723-9. PubMed ID: 9542723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection and Qualification of Simplified QSP Models When Using Model Order Reduction Techniques.
    Hasegawa C; Duffull SB
    AAPS J; 2017 Nov; 20(1):2. PubMed ID: 29181592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologically based pharmacodynamic models: tools for toxicological research and risk assessment.
    Conolly RB; Andersen ME
    Annu Rev Pharmacol Toxicol; 1991; 31():503-23. PubMed ID: 2064384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic modeling.
    Strand SE; Zanzonico P; Johnson TK
    Med Phys; 1993; 20(2 Pt 2):515-27. PubMed ID: 8492760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of permanence time, exit time, dilution factor, and steady-state volume of distribution.
    Mordenti J; Rescigno A
    Pharm Res; 1992 Jan; 9(1):17-25. PubMed ID: 1589404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
    Gabrielsson J; Green AR
    J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance, turnover time, and volume of distribution.
    Rescigno A
    Pharmacol Res; 1997 Mar; 35(3):189-93. PubMed ID: 9229407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why are pharmacokinetic data summarized by arithmetic means?
    Julious SA; Debarnot CA
    J Biopharm Stat; 2000 Feb; 10(1):55-71. PubMed ID: 10709801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized stochastic compartmental models with Erlang transit times.
    Matis JH; Wehrly TE
    J Pharmacokinet Biopharm; 1990 Dec; 18(6):589-607. PubMed ID: 2280350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sojourn time and its use in pharmacology.
    Segre G; Urso R
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():501-6. PubMed ID: 1820930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.